CATALYST DOSSIER · UPDATED 2026-11-06
$CDNL
industrials · convergence -37 · conviction AVOID
Price & Live Quote Loading live quote & chart…
Practice trade tools Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.
Paper trade unavailable: missing risk-bounded frame
Reference only. Not financial advice. No brokerage order is placed.
Why $CDNL?
Quantitative
Net Income (CY2026Q2) : $4.7M (-34.8% YoY)
Catalysts
Deal terms : earnout 2026-10-19
Deal terms : earnout 2026-10-19
Risks
Position-sizing discipline : Conviction AVOID (-37 score) — size accordingly; no specific catalyst-fade risk flagged
Bear case
Squeeze unwind : Short interest can compress before retail catches the move — entry timing critical
Earnings binary : Print-day moves can swing ±15% — gap risk both directions
Sympathy basket (cerebro)
NVDA via semis r=+0.89 sympathetic (score 12)
DIOD via semis r=+0.89 sympathetic (score 10)
NET via tech r=+0.76 sympathetic (score 2)
QBTS via tech r=+0.76 sympathetic (score -1)
MRNA via biotech r=+0.61 sympathetic (score 41)
ELAN via biotech r=+0.61 sympathetic (score 18)
Signals Firing
earnings finra_short auto_macro_adp_payrolls auto_macro_durable_goods auto_macro_fx_rates auto_macro_yield_curve
Pick Track Record Date List Next-day max run Next-day close Hit +2%? 2026-10-01 sec_clean_gappers +5.4% +3.3% ✓ hit 2026-10-01 sec_top_gappers +5.4% +3.3% ✓ hit 2026-10-01 sec_top_moat_emerging +5.4% +3.3% ✓ hit 2026-09-11 sec_clean_gappers -0.2% -5.9% — 2026-09-11 sec_top_gappers -0.2% -5.9% — 2026-09-11 sec_top_moat_emerging -0.2% -5.9% —
Lifetime: 3/6 wins · hit-rate 50.0% on +2% intraday
Sympathy Basket NVDA via semis · score 12 DIOD via semis · score 10 NET via tech · score 2 QBTS via tech · score -1 MRNA via biotech · score 41 ELAN via biotech · score 18
Earnings Catalyst No recent earnings event.
Generate full earnings report
Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks
and its losses — see the
trust report and
methodology .
Not financial advice. Confirm independently before trading.